Have a personal or library account? Click to login
Predictors of Left Ventricular Remodeling Post Acute Myocardial Infarction. Protocol for a Clinical Study Cover

Predictors of Left Ventricular Remodeling Post Acute Myocardial Infarction. Protocol for a Clinical Study

Open Access
|Nov 2019

References

  1. 1. Butler J. Congestive heart failure special issue on advanced heart failure. Congest Heart Fail. 2011;17:159.10.1111/j.1751-7133.2011.00237.x
  2. 2. Tang W, Harper Y, Butler J, Cho L, Hazen S. Risk prediction of incident heart failure in a preventive cardiology clinic: validation of the health abc heart failure risk score with natriuretic peptide testing. Journal of Cardiac Failure. 2010;16:S81.10.1016/j.cardfail.2010.06.283
  3. 3. Yu C, Fung J, Zhang Q, et al. Tissue doppler imaging is superior to strain rate imaging and postsystolic shortening on the prediction of reverse remodeling in both ischemic and nonischemic heart failure after cardiac resynchronization therapy. Circulation. 2004;110:66-73.10.1161/01.CIR.0000133276.45198.A5
  4. 4. Athanasuleas C, Buckberg G, Stanley A. Surgical ventricular restoration in the treatment of congestive heart failure due to post-infarction ventricular dilation. J Am Coll Cardiol. 2005;14:37-38.10.1016/j.accreview.2004.12.024
  5. 5. Norris R. Progressive left ventricular dysfunction and remodeling after myocardial infarction. Circulation. 1994;89:1905.10.1161/circ.89.4.8149558
  6. 6. Cohn J, Ferrari R, Sharpe N. Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. J Am Coll Cardiol. 2000;35:569-582.10.1016/S0735-1097(99)00630-0
  7. 7. Frangogiannis N. The inflammatory response in myocardial infarction. Nat Rev Cardiol. 2002;53:31-47.10.1016/S0008-6363(01)00434-5
  8. 8. Richards A, Nicholls M, Yandle T, et al. Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction. Heart. 1999;81:114-120.10.1136/hrt.81.2.114
  9. 9. Tomaselli G. Electrophysiological remodeling in hypertrophy and heart failure. Cardiovasc Res. 1999;42:270-283.10.1016/S0008-6363(99)00017-6
  10. 10. Nambiar D. Cardiac and extra cardiac predictors and complications of acute atrial fibrillation complicating st elevation myocardial infarction (STEMI) ST elevation myocardial infarction acute atrial fibrillation (STAAF) study. Journal of Medical Science and Clinical Research. 2017;5:22124-22134.10.18535/jmscr/v5i5.139
  11. 11. Yu CM, Fung WH, Lin H, Zhang Q, Sanderson JE, Lau CP. Predictors of left ventricular reverse remodeling after cardiac resynchronization therapy for heart failure secondary to idiopathic dilated or ischemic cardiomyopathy. Am J Cardiol. 2003;91:684-688.10.1016/S0002-9149(02)03404-5
  12. 12. Haque T. Myocardial strain imaging using two and three-dimensional speckle tracking echocardiography: clinical applications. Cardiovascular Journal. 2019;11:167-182.10.3329/cardio.v11i2.40418
  13. 13. Edvardsen T, Helle-Valle T, Smiseth O. Systolic dysfunction in heart failure with normal ejection fraction: speckle-tracking echocardiography. Prog Cardiovasc Dis. 2006;49:207-214.10.1016/j.pcad.2006.08.008
  14. 14. Geyer H, Caracciolo G, Abe H, et al. Assessment of myocardial mechanics using speckle tracking echocardiography: fundamentals and clinical applications. J Am Soc Echocardiogr. 2010;23:351-369.10.1016/j.echo.2010.02.015
  15. 15. Blessberger H, Binder T. Two dimensional speckle tracking echocardiography: basic principles. Heart. 2010;96:716-722.10.1136/hrt.2007.141002
  16. 16. Troughton R, Frampton C, Yandle T, Espine E, Nicholls M, Richards A. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. The Lancet. 2000;355:1126-1130.10.1016/S0140-6736(00)02060-2
  17. 17. Mukoyama M, Nakao K, Hosoda K, et al. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest. 1991;87:1402-1412.10.1172/JCI1151462951841849149
  18. 18. Daniels L, Maisel A. B-type natriuretic peptide: time to incorporate natriuretic peptides in our practice. J Cardiovasc Med (Hagerstown). 2006;7:414-415.10.2459/01.JCM.0000228691.17581.7016721203
  19. 19. Maisel A, Krishnawswamy P, Nowak R. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;11:55.10.1016/S1062-1458(02)00937-6
  20. 20. Neuhold S, Huelsmann M, Strunk G, et al. Comparison of copeptin B-type natriuretic peptide and amino-terminal pro-B-Type natriuretic peptide in patients with Chronic Heart Failure: Prediction of death at different stages of the disease. J Am Coll Cardiol. 2008;52:266-72.10.1016/j.jacc.2008.03.05018634981
  21. 21. Kass DA, Baughman KL, Pak PH, et al. Reverse remodeling from cardiomyoplasty in human heart failure: external constraint versus active assist. Circulation. 1995;91:2314-2318.10.1161/01.CIR.91.9.23147729016
  22. 22. Koitabashi N, Kass D. Reverse remodeling in heart failure-mechanisms and therapeutic opportunities. Nat Rev Cardiol. 2011;9:147-157.10.1038/nrcardio.2011.17222143079
  23. 23. Cinteza M. Reverse remodeling: does this work? Maedica (Buchar). 2015;10:83-84.
DOI: https://doi.org/10.2478/jim-2019-0025 | Journal eISSN: 2501-8132 | Journal ISSN: 2501-5974
Language: English
Page range: 120 - 123
Submitted on: Jun 11, 2019
Accepted on: Aug 21, 2019
Published on: Nov 12, 2019
Published by: Asociatia Transilvana de Terapie Transvasculara si Transplant KARDIOMED
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2019 Ioana Cîrneală, Diana Opincariu, István Kovács, Monica Chițu, Imre Benedek, published by Asociatia Transilvana de Terapie Transvasculara si Transplant KARDIOMED
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.